欧美一区二区三区精品啪啪,久久爱在免费线看观看国产,99久久精品久久久久久清纯,欧美精品中文字幕久久日,国产婷婷色一区二区三区深爱,国产伦子一区二区三区,亚洲精品一区二区大全,国产激情一区二区三区在线观看

  Recently, Dr. Regina Fritsche Danielson, Senior Vice President and Head of Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), AstraZeneca BioPharmaceuticals R&D, led a delegation to visit Cholesgen to discuss their early-stage drug development collaboration. To date, the joint collaboration efforts in early-stage drug development have progressed smoothly and are delivering to plan. During the visit, AstraZeneca recognized the team for the project’s execution, as well as Cholesgen’s R&D capabilities and professional expertise and both parties reviewed the existing collaboration outcomes and discussed potential for further opportunities.

 近日，阿斯利康全球高級副總裁，心血管、腎病及代謝疾病早期研發(fā)負(fù)責(zé)人Regina Fritsche Danielson博士率團(tuán)訪問珂闌醫(yī)藥，就雙方在早期藥物開發(fā)領(lǐng)域的合作展開交流。目前雙方在早期藥物開發(fā)方面的聯(lián)合合作進(jìn)展順利，按計(jì)劃有序推進(jìn)。

  訪問期間，阿斯利康對項(xiàng)目執(zhí)行情況、珂闌醫(yī)藥的研發(fā)實(shí)力與專業(yè)能力給予了認(rèn)可；雙方共同回顧了現(xiàn)有合作成果，并探討了未來進(jìn)一步深化合作的潛在機(jī)會。